Aktiesnakken — Oktober 2009
-
men worst case er at greentech skal have 5%
-
vurderingen herfra er at det IKKE vil have indflyselse på lanceringen af produktet
-
Helt sikkert, hvis jeg havde gang i en vindmøllepark modtog jeg gladeligt royalties fra noget biotech der ville give en skilling

-
hvad er det for en melding fra Genmab?- er der noget nyhedsstof i den?
-
føj da.. troede lige jeg skulle høre en kedelig slutning.... det er grimt sådan noget, og så en tøs på 12 år
-
ja....
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind